Clinical Trial Update: Markers for Early Detection of Prostate Cancer

View source ↗

Summary

This completed clinical trial investigated biomarkers for early detection of prostate cancer. The study was sponsored by the National Cancer Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Status: COMPLETED